Bruton's Tyrosine Kinase (BTK) Inhibition in B-cell Lymphomas
Clinical trial NCT02055924 · TERMINATED
Trial details
- NCT number
- NCT02055924
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-26
- Primary completion
- 2017-12-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.